Stroke and altered mental state increase risk of death for COVID-19 patients medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
New York, Dec 19 (PTI) People hospitalised with COVID-19 and neurological problems including stroke and confusion, have a higher risk of dying than other patients infected with the novel coronavirus, according to a new study. The research, published in the journal Neurology the medical journal of the American Academy of Neurology assessed data from 4,711 COVID-19 patients who were admitted to the Montefiore Medical Center in the US during the six-week period between March 1, 2020 and April 16, 2020. According to the scientists, including those from Albert Einstein College of Medicine in the US, 581 of the 4,711 patients had neurological problems serious enough to warrant brain imaging.
E-Mail
December 18, 2020 (BRONX, NY) People hospitalized with COVID-19 and neurological problems including stroke and confusion, have a higher risk of dying than other COVID-19 patients, according to a study published online today by researchers at Montefiore Health System and Albert Einstein College of Medicine in the journal
Neurology®, the medical journal of the American Academy of Neurology. These findings have the potential to identify and focus treatment efforts on individuals most at risk and could decrease COVID-19 deaths.
The study looked at data from 4,711 COVID-19 patients who were admitted to Montefiore during the six-week period between March 1, 2020 and April 16, 2020. Of those patients, 581 (12%) had neurological problems serious enough to warrant brain imaging. These individuals were compared with 1,743 non-neurological COVID-19 patients of similar age and disease severity who were admitted during the same period.
The U.S. new cases 7-day rolling average are 3.1 % HIGHER than the 7-day rolling average one week ago. U.S. deaths due to coronavirus are now 11.9 %
HIGHER than the rolling average one week ago. U.S. hospitalizations due to COVID-19 are now 6.2 %
HIGHER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are at a record 247,000
U.S. Coronavirus deaths are at a record 3,656
U.S. Coronavirus hospitalizations are at a record 113,069
The 7-day rolling average rate of growth of the pandemic shows new cases marginally worsened, hospitalizations marginally improved, and deaths worsened
Stay-at-Home Orders Not An Effective Tool In Government Pandemic Response.
Athena Therapeutics Announces Initial Financing From HighCape Capital And Connecticut Innovations
Share Article NEW HAVEN, Conn. (PRWEB) December 17, 2020
Athena Therapeutics today announced the closing of an initial financing round with HighCape Capital and Connecticut Innovations. This round of funding will provide the necessary resources to create an innovative cancer drug company that combines world-class scientists, powerful intellectual property, support from Yale University, and a leadership team with extensive experience building successful life sciences companies.
Utilizing discoveries and intellectual property licensed from Yale, Athena will focus on exploiting unique metabolic defects in cancer with the goal of developing transformative therapeutics to treat various forms of cancer.